Demars Financial Group, LLC Abb Vie Inc. Transaction History

Demars Financial Group, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 20, 2023	SELL	$132.51 - $164.9 $74,603 - $92,838	-563 Reduced 5.35%	9,961 $1.34 Million
Q1 2023 Apr 20, 2023	SELL	$144.61 - $166.54 $141,717 - $163,209	-980 Reduced 8.52%	10,524 $1.68 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $133,054 - $159,566	-962 Reduced 7.72%	11,504 $1.86 Million
Q3 2022 Oct 21, 2022	BUY	$134.21 - $153.93 $673,734 - $772,728	5,020 Added 67.42%	12,466 $1.67 Million
Q2 2022 Jul 22, 2022	SELL	$137.62 - $174.96 $302,764 - $384,912	-2,200 Reduced 22.81%	7,446 $1.14 Million
Q1 2022 Apr 27, 2022	SELL	$131.98 - $163.75 $59,390 - $73,687	-450 Reduced 4.46%	9,646 $1.56 Million
Q4 2021 Feb 02, 2022	BUY	$107.43 - $135.93 $728,697 - $922,013	6,783 Added 204.74%	10,096 $1.37 Million
Q3 2021 Oct 15, 2021	SELL	$106.4 - $120.78 $61,286 - $69,569	-576 Reduced 14.81%	3,313 $357,000
Q2 2021 Jul 16, 2021	BUY	$105.21 - $117.21 $10,521 - $11,721	100 Added 2.64%	3,889 $438,000
Q1 2021 Apr 13, 2021	SELL	$102.3 - $112.62 $1,023 - $1,126	-10 Reduced 0.26%	3,789 $410,000
Q4 2020 Jan 25, 2021	SELL	$80.49 - $108.67 $2,012 - $2,716	-25 Reduced 0.65%	3,799 $407,000
Q3 2020 Oct 21, 2020	BUY	$85.91 - $100.83 $21,821 - $25,610	254 Added 7.11%	3,824 $335,000
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $9,904 - $13,254	135 Added 3.93%	3,570 $351,000
Q1 2020 Apr 27, 2020	BUY	$64.5 - $97.79 $221,557 - $335,908	3,435 New	3,435 $262,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Demars Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Demars Financial Group, LLC with notifications on news.